Apogee eczema data drive hype to new peak as threat to Lilly and Sanofi becomes clear
Apogee eczema data drive hype to new peak as threat to Lilly and Sanofi becomes clear
Body unavailable. Use the original source.
Apogee eczema data drive hype to new peak as threat to Lilly and Sanofi becomes clear
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.